NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Shepherd, Finkelman, Miller & Shah, LLP (“SFMS”) announces that a class action lawsuit has been filed in the United States District Court for the District of New Jersey (Civil Action No. 17-08945) against Antares Pharma, Inc. (“Antares” or the “Company”) (Nasdaq:ATRS) and certain of its officers and directors. The case seeks remedies under the Securities Exchange Act of 1934 and is brought on behalf of a class consisting of all persons or entities that acquired Antares securities between December 21, 2016 and October 12, 2017, inclusive (the “Class Period”). If you would like to discuss this action or have any questions regarding this notice or your rights, please contact either Bruce Parke (bparke@sfmslaw.com) or Jonathan Dilger (jdilger@sfmslaw.com); (866) 540-5505.
On December 21, 2016, the Company submitted its New Drug Application (“NDA”) for one of its lead product candidates, Xyosted. The Complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Antares failed to provide the FDA with sufficient data in connection with its NDA for Xyosted; (2) accordingly, the Company had exaggerated Xyosted’s chances of being approved; and (3) as a result of the foregoing, Antares’ public statements were materially false and misleading at all relevant times.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN AN ATTORNEY. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS TIME. If you purchased or otherwise acquired Antares securities during the Class Period, we encourage you to contact us with any questions prior to the December 22, 2017 lead plaintiff motion deadline.
SFMS is recognized as an accomplished firm in the areas of securities, corporate governance, antitrust and employee benefits litigation with offices in California, Connecticut, Florida, New Jersey, New York and Pennsylvania, as well as affiliate offices in London, England, and Milan, Italy. SFMS has recovered hundreds of millions of dollars on behalf of investors. For more information, please visit us at http://www.sfmslaw.com.
Contacts:
Bruce Parke
Jonathan Dilger
Shepherd Finkelman Miller & Shah, LLP
Telephone: (866) 540-5505
Email: bparke@sfmslaw.com